MOORE CAPITAL MANAGEMENT, LP
Position in TERN — Terns Pharmaceuticals, Inc.
CIK 1448574
NEW YORK, NY
Position in TERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Derivatives in TERN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
81,700 | $15,300,776 | |
| 2 | GMAB |
Genmab A/S
|
420,487 | $11,550,777 | |
| 3 | TECH |
BIO-TECHNE Corp
|
125,626 | $8,875,476 | |
| 4 | IMCR |
Immunocore Holdings plc
|
274,663 | $8,720,550 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
414,005 | $7,746,033 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
305,794 | $6,791,684 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
75,588 | $6,165,713 | |
| 8 | SLDB |
Solid Biosciences Inc.
|
603,472 | $6,028,685 |
All Filings in TERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 50,000 | Call | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||